Dow Down 0.13% Nasdaq Up 0.14%

Navidea Biopharmaceuticals, Inc (NAVB)

-NYSE MKT
0.54 Up 0.01(1.77%) Jul 29, 4:02PM EDT
Prev Close:0.53
Open:0.53
Bid:0.41 x 100
Ask:0.86 x 38800
1y Target Est:1.25
Beta:-0.051717
Next Earnings Date: 4-Aug-16NAVB Earnings announcement
Day's Range:0.52 - 0.56
52wk Range:0.47 - 2.50
Volume:291,321
Avg Vol (3m):1,070,970
Market Cap:83.87M
P/E (ttm):N/A
EPS (ttm):-0.16
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for NAVB

Comparison

Symbol% ChgMkt Cap
NAVBUp 1.77%83.87M
LLYDown 0.05%87.47B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):5.20
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.08
Quarterly EPS Est (Jun-16) :-0.03
Mean Recommendation*:5.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback